Picture of Cochlear logo

COH — Cochlear Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareConservativeLarge CapFalling Star

Momentum

Relative Strength (%)
1m-4.94%
3m-8.91%
6m-18.71%
1yr-5.84%
Volume Change (%)
10d/3m-12.35%
Price vs... (%)
52w High-22.09%
50d MA-7.68%
200d MA-11.99%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)43.54
PEG Ratio (f)n/a
EPS Growth (f)-1.19%
Dividend Yield (f)1.65%
Valuation (ttm)IndustryMarket
Price to Book Value7.76
Price to Tang. Book10.17
Price to Free Cashflow66.45
Price to Sales8.82
EV to EBITDA30.68

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital18.38%
Return on Equity21.04%
Operating Margin24.98%

Financial Summary

Year End 30th JunUnit201720182019202020212022E2023ECAGR / Avg
Total RevenueAU$m1,253.841,363.71,426.71,320.61,497.61,655.241,835.695.78%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+14+8.52+9.09+16.86-5.85-18.94+16.49n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for COH

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202230th Jun 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Cochlear EPS forecast chart

Profile Summary

Cochlear Limited is an Australia-based company, which provides implantable hearing solutions. The Company designs and offers products and accessories for adults or children. The Company operates through three segments: cochlear implants, services and acoustics. Cochlear implants segment offers cochlear implant systems, including Cochlear, Nucleus, Profile Plus implant and Slim Modiolar Electrode (CI632). Services segment offers sound processor upgrades, accessories and other, including Cochlear Nucleus 7 Sound Processor, Cochlear Nucleus Kanso 2 Sound Processor and Cochlear Baha 6 Max Sound Processor. Acoustics segment offers bone conduction systems and sound processor upgrades, including Cochlear Osia 2 System. The Company operates in America; Europe, the Middle East and Africa (EMEA); and Asia Pacific.

Directors

Last Annual
June 30th, 2021
Last Interim
June 30th, 2021
Incorporated
June 8th, 1983
Public Since
December 4th, 1995
No. of Shareholders
44,517
No. of Employees
4,000
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
au flag iconAustralian Stock Exchange - SEATS
Shares in Issue
65,744,078

COH Share Price Performance

Similar to COH

Picture of 4DMedical logo

4DMedical

au flag iconAustralian Stock Exchange - SEATS

Picture of Adherium logo

Adherium

au flag iconAustralian Stock Exchange - SEATS

Picture of Allegra Orthopaedics logo

Allegra Orthopaedics

au flag iconAustralian Stock Exchange - SEATS

Picture of Analytica logo

Analytica

au flag iconAustralian Stock Exchange - SEATS

Picture of Ansell logo

Ansell

au flag iconAustralian Stock Exchange - SEATS

FAQ

Or unlock with your email

Or unlock with your email